Tempest Therapeutics (TPST) Shares Outstanding (2011 - 2026)

Tempest Therapeutics has disclosed Shares Outstanding (Entity) across 15 years of filings, most recently posting $4.9 million for Q4 2025.

• In Q4 2025, Shares Outstanding (Entity) rose 129.58% year-over-year to $4.9 million; the TTM figure through Dec 2025 stood at $4.9 million (up 129.58% YoY), while the FY2025 annual figure was $4.9 million, up 129.58% from the prior year.
• Shares Outstanding (Entity) came in at $4.9 million for Q4 2025 at Tempest Therapeutics, up from $4.4 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $4.9 million in Q4 2025 to a low of $71184.0 in Q2 2021.
• Average Shares Outstanding (Entity) over 5 years is $1.7 million, with a median of $1.1 million recorded in 2023.
• Year-over-year, Shares Outstanding (Entity) slipped 26.94% in 2021 and surged 1015.74% in 2022.
• Over 5 years, Shares Outstanding (Entity) stood at $291550.0 in 2021, then soared by 177.51% to $809086.0 in 2022, then soared by 46.56% to $1.2 million in 2023, then surged by 80.99% to $2.1 million in 2024, then soared by 129.58% to $4.9 million in 2025.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $4.9 million in Q4 2025, $4.4 million in Q3 2025, and $4.4 million in Q2 2025.